AFC-HD AMS Life Science
AFC-HD AMS Life Science Co.,Ltd.
Company highlights
The largest segment by revenue is Health care, at 60.9% of the total.
Key figures
Period Sep 2024 to Aug 2025ConsolidatedJapanese GAAP
Company profile
Tables scroll sideways
Disclosed data
Business activities and revenue composition
AFC-HD AMS Life Science
Revenue and profit by business segment
Period Sep 2024 to Aug 2025Source Annual securities reportsConsolidated・Disclosed
| Business | Net sales to external customers | Operating income | ||||
|---|---|---|---|---|---|---|
| This year | Share | Last year | This year | Margin | Last year | |
| Health care | ¥18.9 billion | 60.9% | ¥18.1 billion | ¥2.5 billion | 13.0% | ¥2.2 billion |
| Department store business | ¥4.6 billion | 14.9% | ¥4.9 billion | ¥61.80 million | 1.3% | ¥33.40 million |
| Real Estate and Consignment Business | ¥2.7 billion | 8.6% | ¥1.9 billion | ¥16.57 million | 0.6% | ¥-0.3 billion |
| Medical products | ¥2.5 billion | 8.0% | ¥2.3 billion | ¥0.2 billion | 9.3% | ¥0.2 billion |
| Food service business | ¥2.4 billion | 7.6% | ¥2.2 billion | ¥-74.87 million | -3.2% | ¥-70.98 million |
| Total of the businesses | ¥31.0 billion | 100.0% | ||||
Revenue and profit
AFC-HD AMS Life Science
Period Sep 2024 to Aug 2025Source Annual securities reports
Amounts by account
| Group | Account | Amount | Consolidated / Non-consolidated |
|---|---|---|---|
| Selling, general and administrative expenses | Salaries and allowances | ¥2.8 billion | Consolidated |
| Advertising expenses | ¥0.8 billion | Consolidated | |
| Amortization of goodwill | ¥0.3 billion | Consolidated | |
| Promotion expenses | ¥0.2 billion | Parent only | |
| Research and development expenses | ¥0.1 billion | Consolidated | |
| Provision for bonuses | ¥90.03 million | Consolidated | |
| Legal welfare expenses | ¥65.16 million | Parent only | |
| Retirement benefit expenses | ¥54.10 million | Consolidated | |
| Rents | ¥46.50 million | Parent only | |
| Fee expenses | ¥43.57 million | Parent only | |
| Provision for directors' retirement benefits | ¥34.62 million | Consolidated | |
| Provision for shareholder benefit program | ¥32.03 million | Consolidated | |
| Depreciation | ¥21.99 million | Parent only | |
| Provision of allowance for doubtful accounts | ¥-1.19 million | Consolidated | |
| Profit by stage | Gross profit (loss) | ¥11.3 billion | Consolidated |
| Ordinary income | ¥2.4 billion | Consolidated | |
| Operating income | ¥2.4 billion | Consolidated | |
| Net income | ¥1.4 billion | Consolidated |
AFC-HD AMS Life Science
Selling, general and administrative expenses
Period Sep 2024 to Aug 2025Source Annual securities reports
- Salaries and allowances ¥2.8 billion
- Advertising expenses ¥0.8 billion
- Amortization of goodwill ¥0.3 billion
- Promotion expenses ¥0.2 billion
- Research and development expenses ¥0.1 billion
- Provision for bonuses ¥0.1 billion
- Other (not itemized) ¥4.6 billion
Performance, financial position and capital allocation
Long-term changes in performance
AFC-HD AMS Life Science
Long-term revenue, profit and asset trends
Period 2012 to 2025Source Annual securities reportsDisclosed
AFC-HD AMS Life Science
Recent performance trends
Source Annual securities reports
Year-on-year comparison
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Net sales | ¥22.4B | ¥23.0B | ¥25.6B | ¥30.2B | ¥32.7B |
| Year on year (%) | +41.4%◆ | +2.9% | +11.1% | +18.0% | +8.2% |
| Ordinary income (loss) | ¥2.2B | ¥1.3B | ¥1.7B | ¥1.9B | ¥2.4B |
| Change from prior year | +96.6% | -37.9% | +23.1% | +16.2% | +27.2% |
| Ordinary income (loss) as a share of Net sales | 9.7% | 5.8% | 6.5% | 6.4% | 7.5% |
| Change (percentage points) | +2.7 points◆ | -3.8 points◆ | +0.6 points | -0.1 points | +1.1 points |
Fiscal periods marked for changes
- 2015Ordinary income (loss) as a share of revenue +2.5 points
- 2021Net sales year on year +41.4%, Ordinary income (loss) as a share of revenue +2.7 points
- 2022Ordinary income (loss) as a share of revenue -3.8 points
AFC-HD AMS Life Science
Earnings and net assets per share over time
Unit yenSource Annual securities reports
AFC-HD AMS Life Science
Return on equity over time
Unit %Source Annual securities reports
Consolidated indicators (15 items)
| Item | 4 years ago | 3 years ago | 2 years ago | Last year | This year |
|---|---|---|---|---|---|
| Net sales | ¥22.4 billion | ¥23.0 billion | ¥25.6 billion | ¥30.2 billion | ¥32.7 billion |
| Ordinary income (loss) | ¥2.2 billion | ¥1.3 billion | ¥1.7 billion | ¥1.9 billion | ¥2.4 billion |
| Net income (loss) attributable to owners of parent | ¥1.5 billion | ¥0.7 billion | ¥1.1 billion | ¥1.3 billion | ¥1.4 billion |
| Comprehensive income | ¥1.5 billion | ¥0.8 billion | ¥1.1 billion | ¥1.1 billion | ¥1.6 billion |
| Net assets | ¥12.7 billion | ¥12.4 billion | ¥13.2 billion | ¥14.0 billion | ¥15.2 billion |
| Total assets | ¥35.8 billion | ¥37.3 billion | ¥41.1 billion | ¥47.0 billion | ¥48.7 billion |
| Net assets per share | 833.44 yen | 884.53 yen | 938.25 yen | 990.1 yen | 1,069.89 yen |
| Basic earnings (loss) per share | 107.12 yen | 52.33 yen | 78.51 yen | 89.2 yen | 102.98 yen |
| Diluted earnings per share | 106.3 yen | 52.08 yen | 78.46 yen | 89.11 yen | 102.97 yen |
| Equity-to-asset ratio | 33.1% | 33.2% | 31.9% | 29.6% | 30.9% |
| Return on equity | 13.4% | 6.1% | 8.6% | 9.3% | 10.0% |
| Net cash provided by (used in) operating activities | ¥2.6 billion | ¥1.5 billion | ¥0.9 billion | ¥1.5 billion | ¥1.8 billion |
| Net cash provided by (used in) investing activities | ¥-0.3 billion | ¥-1.1 billion | ¥-1.9 billion | ¥-2.8 billion | ¥-3.3 billion |
| Net cash provided by (used in) financing activities | ¥2.2 billion | ¥1.2 billion | ¥1.9 billion | ¥2.2 billion | ¥0.7 billion |
| Cash and cash equivalents | ¥8.7 billion | ¥10.3 billion | ¥11.1 billion | ¥12.1 billion | ¥11.2 billion |
Parent only indicators (15 items)
| Item | 4 years ago | 3 years ago | 2 years ago | Last year | This year |
|---|---|---|---|---|---|
| Net sales | ¥14.4 billion | ¥11.6 billion | ¥11.9 billion | ¥14.1 billion | ¥14.9 billion |
| Ordinary income (loss) | ¥1.2 billion | ¥1.0 billion | ¥1.3 billion | ¥1.4 billion | ¥1.2 billion |
| Net income (loss) | ¥0.9 billion | ¥0.7 billion | ¥1.0 billion | ¥1.0 billion | ¥0.7 billion |
| Capital stock | ¥2.1 billion | ¥2.1 billion | ¥2.1 billion | ¥2.1 billion | ¥2.1 billion |
| Total number of issued shares (common stock) | 14,387,699 shares | 14,387,699 shares | 14,387,699 shares | 14,387,699 shares | 14,391,199 shares |
| Net assets | ¥10.1 billion | ¥10.2 billion | ¥10.7 billion | ¥11.3 billion | ¥11.6 billion |
| Total assets | ¥26.5 billion | ¥27.6 billion | ¥29.2 billion | ¥31.5 billion | ¥32.5 billion |
| Net assets per share | 705.25 yen | 722.39 yen | 764.17 yen | 800.93 yen | 822.1 yen |
| Dividend per share | 27.5 yen | 30 yen | 27.5 yen | 30 yen | 34 yen |
| Interim dividend per share | 12.5 yen | 15 yen | 12.5 yen | 15 yen | 16 yen |
| Basic earnings (loss) per share | 62.15 yen | 51.55 yen | 67.93 yen | 69.06 yen | 50.25 yen |
| Diluted earnings per share | 61.67 yen | 51.31 yen | 67.88 yen | 68.99 yen | 50.25 yen |
| Equity-to-asset ratio | 37.7% | 36.7% | 36.6% | 35.8% | 35.6% |
| Return on equity | 9.0% | 7.2% | 9.2% | 8.8% | 6.2% |
| Payout ratio | 44.2% | 58.2% | 40.5% | 43.4% | 67.7% |
Dividend history
| Fiscal year | Annual dividend per share | Of which interim | Payout ratio (as reported, parent only) | Flag |
|---|---|---|---|---|
| FY ending 8/2025 | ¥34 | ¥16 | 67.7% | |
| FY ending 8/2024 | ¥30 | ¥15 | 43.4% | |
| FY ending 8/2023 | ¥27.5 | ¥12.5 | 40.5% | |
| FY ending 8/2022 | ¥30 | ¥15 | 58.2% | |
| FY ending 8/2021 | ¥27.5 | ¥12.5 | 44.2% | |
| FY ending 8/2020 | ¥20 | ¥10 | 51.2% | |
| FY ending 8/2019 | ¥25 | ¥10 | 60.7% | |
| FY ending 8/2018 | ¥20 | ¥10 | 40.5% | |
| FY ending 8/2017 | ¥10 | ¥5 | 55.5% | |
| FY ending 8/2016 | ¥15 | ¥5 | 99.1% | |
| FY ending 8/2015 | ¥15 | ¥5 | 36.7% | |
| FY ending 8/2014 | ¥10 | ¥5 | 44.1% | |
| FY ending 8/2013 | ¥15 | ¥5 | 32.9% | |
| FY ending 8/2012 | ¥10 | ¥5 | 21.0% |
AFC-HD AMS Life Science
Dividends per share over time
Unit yenSource Annual securities reports
Shareholder composition
Share ownership by holder category
AFC-HD AMS Life Science
Unit %Source Annual securities reports
- Financial institutions1.01%
- Securities firms1.73%
- Other corporations2.40%
- Foreign holders (institutions)2.96%
- Foreign holders (individuals)0.06%
- Individuals and others91.84%
Major shareholders
| Rank | Shareholder | Shareholding ratio | Shares held |
|---|---|---|---|
| 1 | 浅 山 忠 彦 | 14.81% | 2,087,570 |
| 2 | 淺 山 雄 彦 | 8.39% | 1,181,930 |
| 3 | アムスライフサイエンス取引先持株会 | 3.01% | 424,700 |
| 4 | 木 下 圭一郎 | 2.86% | 403,400 |
| 5 | 浅 山 麻衣子 | 2.2% | 310,000 |
| 6 | 浅 山 麻里奈 | 2.13% | 300,000 |
| 7 | 藤 田 圭 亮 | 0.92% | 129,167 |
| 8 | 株式会社静岡銀行(常任代理人日本マスタートラスト信託銀行株式会社) | 0.89% | 124,900 |
| 9 | STATE STREET BANK AND TRUST COMPANY 510643(常任代理人株式会社みずほ銀行決済営業部) | 0.87% | 123,100 |
| 10 | 福 地 千 佳 | 0.68% | 95,420 |
Research and development expenses and capital expenditure
| Fiscal year | Research and development | Capital expenditure |
|---|---|---|
| FY ending 8/2025 | ¥0.1 billion | ¥3.6 billion |
| FY ending 8/2020 | ¥0.2 billion | ¥0.3 billion |
Research and development expenses and capital expenditure by segment (FY ending 8/2025)
| Segment | Capital expenditure |
|---|---|
| Health care | ¥1.8 billion |
| Department store business | ¥0.7 billion |
| Real Estate and Consignment Business | ¥0.7 billion |
| Medical products | ¥20.24 million |
| Food service business | ¥0.1 billion |
Revenue scale in the same industry
AFC-HD AMS Life Science
Source Annual securities reports of each company
Foods: 130 companies · revenue · largest first・each company’s latest fiscal year・Consolidated・Disclosed
- 1 JAPAN TOBACCOFY Dec 2025 ¥3.5T
- 2 SuntoryFY Dec 2025 ¥3.1T
- 3 ASAHI GROUPFY Dec 2025 ¥2.9T
- … 86 companies
- 90 Ensuiko Sugar RefiningFY Mar 2026 ¥33.0B
- 91 MARUSAN-AIFY Sep 2025 ¥32.9B
- 92 AFC-HD AMS Life ScienceThis companyFY Aug 2025 ¥32.7B
- 93 Ifuji SangyoFY Mar 2026 ¥32.6B
- 94 orion breweriesFY Mar 2026 ¥29.7B
- … 36 companies
Workforce information
Women 210 Employees by gender
Administrative filings and published information
Workplace information filings
| Item | Value |
|---|---|
| Employees | 450 |
| Annual paid leave taken |
72% |
| Share of managers who are women | 24.4% |
| Share of board members who are women | 7.1% |
Greenhouse gas emissions
| Category | Emissions |
|---|---|
| 特定事業所排出者 | 3,577 t-CO2 |
Audit and disclosure information
| Item | Value |
|---|---|
| Audit firm | あおい監査法人 |
| Audit fees (this year, total) | ¥49.00 million |
| Non-audit fees (this year, total) | Not applicable |
| Going concern note | Cannot be determined |
| Accounting standard | Japanese GAAP |
Related books, articles and videos
Sources and methodology
Retrieved disclosed figures
Major management indicators (5 years) (30 items)
| Item | Value | Consolidated / Non-consolidated |
|---|---|---|
| Comprehensive income | ¥1.6 billion | Consolidated |
| Net cash provided by (used in) operating activities | ¥1.8 billion | Consolidated |
| Net sales | ¥32.7 billion | Consolidated |
| Net cash provided by (used in) investing activities | ¥-3.3 billion | Consolidated |
| Diluted earnings per share | 102.97 yen | Consolidated |
| Cash and cash equivalents | ¥11.2 billion | Consolidated |
| Net assets | ¥15.2 billion | Consolidated |
| Ordinary income (loss) | ¥2.4 billion | Consolidated |
| Total assets | ¥48.7 billion | Consolidated |
| Return on equity | 10.0% | Consolidated |
| Equity-to-asset ratio | 30.9% | Consolidated |
| Net income (loss) attributable to owners of parent | ¥1.4 billion | Consolidated |
| Net cash provided by (used in) financing activities | ¥0.7 billion | Consolidated |
| Basic earnings (loss) per share | 102.98 yen | Consolidated |
| Net assets per share | 1,069.89 yen | Consolidated |
| Dividend per share | 34 yen | Parent only |
| Net sales | ¥14.9 billion | Parent only |
| Net income (loss) | ¥0.7 billion | Parent only |
| Diluted earnings per share | 50.25 yen | Parent only |
| Total number of issued shares (common stock) | 14,391,199 shares | Parent only |
| Net assets | ¥11.6 billion | Parent only |
| Ordinary income (loss) | ¥1.2 billion | Parent only |
| Total assets | ¥32.5 billion | Parent only |
| Return on equity | 6.2% | Parent only |
| Equity-to-asset ratio | 35.6% | Parent only |
| Capital stock | ¥2.1 billion | Parent only |
| Payout ratio | 67.7% | Parent only |
| Interim dividend per share | 16 yen | Parent only |
| Basic earnings (loss) per share | 50.25 yen | Parent only |
| Net assets per share | 822.1 yen | Parent only |
Employees (13 items)
| Item | Value | Consolidated / Non-consolidated |
|---|---|---|
| Number of employees | 1,008 people | Consolidated |
| Number of employees | 1,008 people | Consolidated |
| Wage gap between men and women (all employees) | 68.7% | Parent only |
| Average length of service (years) | 9 years | Parent only |
| Average length of service months | 9 months | Parent only |
| Average annual salary | ¥4.32 million | Parent only |
| Average age (years) | 40 years old | Parent only |
| Average age months | 2 months | Parent only |
| Number of employees | 360 people | Parent only |
| Number of employees | 360 people | Parent only |
| Number of employees | 360 people | Parent only |
| Wage gap between men and women (regular employees) | 80.6% | Parent only |
| Wage gap between men and women (non-regular employees) | 59.9% | Parent only |
Other disclosed items (15 items)
| Item | Value | Consolidated / Non-consolidated |
|---|---|---|
| Goodwill before offsetting | ¥1.9 billion | Consolidated |
| Discounted trade notes receivable | ¥32.13 million | Consolidated |
| Net sales to external customers | ¥32.7 billion | Consolidated |
| Average number of temporary employees | 381 people | Consolidated |
| Average number of temporary employees | 381 people | Consolidated |
| Increase in property plant and equipment and intangible assets | ¥3.6 billion | Consolidated |
| Write-downs of inventories | ¥76.87 million | Consolidated |
| Depreciation | ¥1.1 billion | Consolidated |
| Number of consolidated subsidiaries | 23 companies | Consolidated |
| Rate of male employees taking childcare leave (all employees) | 60.0% | Parent only |
| Average number of temporary employees | 75 people | Parent only |
| Average number of temporary employees | 75 people | Parent only |
| Average number of temporary employees | 75 people | Parent only |
| Total return on the share price index | 214.3% | Parent only |
| Ratio of female employees in managerial positions | 24.4% | Parent only |
Shares (16 items)
| Item | Value | Consolidated / Non-consolidated |
|---|---|---|
| Total of dividends received equity securities other than those not listed investment equity securities held for pure investment reporting company | ¥3.22 million | Consolidated |
| Total of gain loss on sale equity securities other than those not listed investment equity securities held for pure investment reporting company | ¥51.06 million | Consolidated |
| Number of shares held | 5,180,187 shares | Consolidated |
| Total number of shares held treasury shares etc | 300,000 shares | Consolidated |
| Number of shares | 14,391,199 shares | Consolidated |
| Shareholding ratio treasury shares etc | 2.1% | Consolidated |
| Shareholding ratio | 36.8% | Consolidated |
| Number of shares held in own name treasury shares etc | 300,000 shares | Consolidated |
| Number of voting rights | 140,808 units | Consolidated |
| Carrying amount on the balance sheet | ¥0 | Consolidated |
| Carrying amount on the balance sheet | ¥59.13 million | Consolidated |
| Book value equity securities other than those not listed investment equity securities held for pure investment reporting company | ¥96.06 million | Consolidated |
| Number of issues | 1 issues | Consolidated |
| Number of issues | 10 issues | Consolidated |
| Number of issues | 1 issues | Consolidated |
| Total shareholder return | 155.7% | Parent only |
Research and development (1 items)
| Item | Value | Consolidated / Non-consolidated |
|---|---|---|
| Research and development expenses | ¥0.1 billion | Consolidated |
Property and facilities (1 items)
| Item | Value | Consolidated / Non-consolidated |
|---|---|---|
| Capital expenditures | ¥3.6 billion | Consolidated |
Audit (3 items)
| Item | Value | Consolidated / Non-consolidated |
|---|---|---|
| Fees for audit and attestation services - reporting company | ¥26.00 million | Consolidated |
| Fees for audit and attestation services - total | ¥49.00 million | Consolidated |
| Fees for audit and attestation services - consolidated subsidiaries | ¥23.00 million | Consolidated |
Accounts unique to this company (9 items)
| Item | Value | Consolidated / Non-consolidated |
|---|---|---|
| Revenue | ¥-5.35 million | Consolidated |
| Revenue | ¥-42.51 million | Consolidated |
| Revenue | ¥29.55 million | Consolidated |
| Revenue | ¥0.88 million | Consolidated |
| Revenue | ¥67.46 million | Consolidated |
| Revenue | ¥0.2 billion | Consolidated |
| Revenue | ¥0.2 billion | Consolidated |
| Revenue | ¥0.88 million | Parent only |
| Revenue | ¥0.2 billion | Parent only |
Balance sheet (132 items)
| Item | Value | Consolidated / Non-consolidated |
|---|---|---|
| Other | ¥0.8 billion | Consolidated |
| Other | ¥2.4 billion | Consolidated |
| Other | ¥1.4 billion | Consolidated |
| Other | ¥1.7 billion | Consolidated |
| Other | ¥1.1 billion | Consolidated |
| Other | ¥0.1 billion | Consolidated |
| Valuation difference on available-for-sale securities | ¥50.47 million | Consolidated |
| Other, net | ¥0.4 billion | Consolidated |
| Goodwill | ¥1.9 billion | Consolidated |
| Work in process | ¥1.2 billion | Consolidated |
| Retained earnings | ¥10.4 billion | Consolidated |
| Raw materials and supplies | ¥1.6 billion | Consolidated |
| Notes receivable - trade | ¥0.1 billion | Consolidated |
| Merchandise and finished goods | ¥1.8 billion | Consolidated |
| Non-current liabilities | ¥7.5 billion | Consolidated |
| Non-current assets | ¥26.4 billion | Consolidated |
| Land | ¥11.2 billion | Consolidated |
| Accounts receivable - trade | ¥2.8 billion | Consolidated |
| Contract liabilities | ¥1.5 billion | Consolidated |
| Contract assets | ¥13.08 million | Consolidated |
| Buildings and structures | ¥23.1 billion | Consolidated |
| Buildings and structures, net | ¥7.1 billion | Consolidated |
| Construction in progress | ¥1.5 billion | Consolidated |
| Provision for directors' retirement benefits | ¥0.3 billion | Consolidated |
| Investments and other assets | ¥3.0 billion | Consolidated |
| Investment securities | ¥0.6 billion | Consolidated |
| Notes and accounts payable - trade | ¥3.6 billion | Consolidated |
| Subscription rights to shares | ¥0.59 million | Consolidated |
| Property, plant and equipment | ¥21.3 billion | Consolidated |
| Income taxes payable | ¥0.5 billion | Consolidated |
| Shareholders' equity | ¥15.0 billion | Consolidated |
| Machinery, equipment and vehicles | ¥4.6 billion | Consolidated |
| Machinery, equipment and vehicles, net | ¥1.1 billion | Consolidated |
| Current liabilities | ¥26.0 billion | Consolidated |
| Current assets | ¥22.3 billion | Consolidated |
| Accumulated depreciation | ¥-1.0 billion | Consolidated |
| Accumulated depreciation | ¥-16.0 billion | Consolidated |
| Accumulated depreciation | ¥-3.5 billion | Consolidated |
| Foreign currency translation adjustment | ¥12.04 million | Consolidated |
| Intangible assets | ¥2.0 billion | Consolidated |
| Cash and cash equivalents | ¥11.2 billion | Consolidated |
| Cash and deposits | ¥11.3 billion | Consolidated |
| Short-term loans payable | ¥9.5 billion | Consolidated |
| Net assets | ¥15.2 billion | Consolidated |
| Net assets | ¥15.2 billion | Consolidated |
| Total assets | ¥48.7 billion | Consolidated |
| Total assets | ¥48.7 billion | Consolidated |
| Deferred tax liabilities | ¥0.2 billion | Consolidated |
| Deferred tax assets | ¥0.2 billion | Consolidated |
| Treasury stock | ¥-0.3 billion | Consolidated |
| Valuation and translation adjustments | ¥0.1 billion | Consolidated |
| Liabilities | ¥33.5 billion | Consolidated |
| Liabilities and net assets | ¥48.7 billion | Consolidated |
| Real estate for sale | ¥2.3 billion | Consolidated |
| Allowance for doubtful accounts | ¥-58.38 million | Consolidated |
| Allowance for doubtful accounts | ¥-15.67 million | Consolidated |
| Capital surplus | ¥2.7 billion | Consolidated |
| Capital stock | ¥2.1 billion | Consolidated |
| Provision for bonuses | ¥0.2 billion | Consolidated |
| Remeasurements of defined benefit plans | ¥54.79 million | Consolidated |
| Net defined benefit liability | ¥0.7 billion | Consolidated |
| Long-term loans payable | ¥5.5 billion | Consolidated |
| Non-controlling interests | ¥0.1 billion | Consolidated |
| Current portion of long-term loans payable | ¥9.0 billion | Consolidated |
| Other | ¥0.1 billion | Parent only |
| Other | ¥0.2 billion | Parent only |
| Other | ¥0.4 billion | Parent only |
| Other | ¥63.35 million | Parent only |
| Valuation difference on available-for-sale securities | ¥17.86 million | Parent only |
| Other capital surplus | ¥0.30 million | Parent only |
| Software | ¥15.52 million | Parent only |
| Work in process | ¥0.9 billion | Parent only |
| General reserve | ¥1.9 billion | Parent only |
| Retained earnings | ¥7.3 billion | Parent only |
| Legal retained earnings | ¥13.38 million | Parent only |
| Prepaid expenses | ¥22.21 million | Parent only |
| Raw materials and supplies | ¥1.2 billion | Parent only |
| Notes receivable - trade | ¥84.64 million | Parent only |
| Merchandise and finished goods | ¥1.1 billion | Parent only |
| Non-current liabilities | ¥2.0 billion | Parent only |
| Non-current assets | ¥13.1 billion | Parent only |
| Land | ¥3.1 billion | Parent only |
| Reserve for reduction entry2 | ¥0.2 billion | Parent only |
| Accounts receivable - trade | ¥2.2 billion | Parent only |
| Contract liabilities | ¥0.3 billion | Parent only |
| Tools, furniture and fixtures | ¥61.73 million | Parent only |
| Buildings, net | ¥2.1 billion | Parent only |
| Construction in progress | ¥1.4 billion | Parent only |
| Provision for directors' retirement benefits | ¥0.2 billion | Parent only |
| Investments and other assets | ¥5.5 billion | Parent only |
| Investment securities | ¥0.2 billion | Parent only |
| Notes payable trade | ¥23.55 million | Parent only |
| Subscription rights to shares | ¥0.59 million | Parent only |
| Property, plant and equipment | ¥7.5 billion | Parent only |
| Income taxes payable | ¥0.2 billion | Parent only |
| Accrued expenses | ¥32.72 million | Parent only |
| Accounts payable - other | ¥0.6 billion | Parent only |
| Provision for shareholder benefit program | ¥85.04 million | Parent only |
| Shareholders' equity | ¥11.6 billion | Parent only |
| Structures, net | ¥29.96 million | Parent only |
| Machinery and equipment, net | ¥0.8 billion | Parent only |
| Current liabilities | ¥18.9 billion | Parent only |
| Current assets | ¥19.4 billion | Parent only |
| Intangible assets | ¥78.87 million | Parent only |
| Cash and deposits | ¥4.4 billion | Parent only |
| Short-term loans payable | ¥6.7 billion | Parent only |
| Short-term loans receivable with resale agreement | ¥1.2 billion | Parent only |
| Net assets | ¥11.6 billion | Parent only |
| Net assets | ¥11.6 billion | Parent only |
| Total assets | ¥32.5 billion | Parent only |
| Deferred tax assets | ¥0.1 billion | Parent only |
| Retained earnings brought forward | ¥5.1 billion | Parent only |
| Treasury stock | ¥-0.3 billion | Parent only |
| Valuation and translation adjustments | ¥17.86 million | Parent only |
| Liabilities | ¥20.9 billion | Parent only |
| Liabilities and net assets | ¥32.5 billion | Parent only |
| Accounts payable - trade | ¥1.9 billion | Parent only |
| Allowance for doubtful accounts | ¥-41.96 million | Parent only |
| Allowance for doubtful accounts | ¥-7.00 million | Parent only |
| Capital surplus | ¥2.4 billion | Parent only |
| Legal capital surplus | ¥2.4 billion | Parent only |
| Capital stock | ¥2.1 billion | Parent only |
| Provision for bonuses | ¥0.1 billion | Parent only |
| Vehicles, net | ¥2.72 million | Parent only |
| Provision for retirement benefits | ¥0.4 billion | Parent only |
| Long-term loans payable | ¥1.5 billion | Parent only |
| Long-term prepaid expenses | ¥1.88 million | Parent only |
| Investments in capital of subsidiaries and affiliates | ¥0.2 billion | Parent only |
| Shares of subsidiaries and associates | ¥5.0 billion | Parent only |
| Deposits received | ¥44.99 million | Parent only |
| Long term borrowings scheduled for collection within the year | ¥8.0 billion | Parent only |
| Current portion of long-term loans payable | ¥8.7 billion | Parent only |
Statement of income (111 items)
| Item | Value | Consolidated / Non-consolidated |
|---|---|---|
| Other | ¥71.82 million | Consolidated |
| Other | ¥50.08 million | Consolidated |
| Other | ¥1.86 million | Consolidated |
| Other | ¥0.02 million | Consolidated |
| Other comprehensive income | ¥0.1 billion | Consolidated |
| Valuation difference on available for sale securities net of tax | ¥0.1 billion | Consolidated |
| Amortization of goodwill | ¥0.3 billion | Consolidated |
| Amortization of goodwill | ¥0.3 billion | Consolidated |
| Amortization of goodwill | ¥0.3 billion | Consolidated |
| Business structure improvement expenses | ¥16.42 million | Consolidated |
| Gain on forgiveness of debts | ¥0.3 billion | Consolidated |
| Dividends from surplus | ¥-0.4 billion | Consolidated |
| Comprehensive income | ¥1.6 billion | Consolidated |
| Interest income | ¥10.78 million | Consolidated |
| Rent income | ¥24.50 million | Consolidated |
| Dividend income | ¥13.51 million | Consolidated |
| Operating income | ¥2.4 billion | Consolidated |
| Operating income | ¥2.4 billion | Consolidated |
| Non-operating income | ¥0.3 billion | Consolidated |
| Non-operating expenses | ¥0.3 billion | Consolidated |
| Net cash provided by (used in) operating activities | ¥1.8 billion | Consolidated |
| Gain on Donated Fixed Assets | ¥79.22 million | Consolidated |
| Loss on sale of non-current assets | ¥3.76 million | Consolidated |
| Gain on sales of non-current assets | ¥1.04 million | Consolidated |
| Loss on retirement of non-current assets | ¥21.54 million | Consolidated |
| Cost of sales | ¥21.4 billion | Consolidated |
| Gross profit (loss) | ¥11.3 billion | Consolidated |
| Net sales | ¥32.7 billion | Consolidated |
| Net sales | ¥32.7 billion | Consolidated |
| Advertising expenses | ¥0.8 billion | Consolidated |
| Net income | ¥1.4 billion | Consolidated |
| Net income | ¥1.4 billion | Consolidated |
| Net income (loss) | ¥1.5 billion | Consolidated |
| Net income (loss) | ¥1.5 billion | Consolidated |
| Provision for directors' retirement benefits | ¥34.62 million | Consolidated |
| Gain on sales of investment securities | ¥81.45 million | Consolidated |
| Loss on valuation of investment securities | ¥69.72 million | Consolidated |
| Net cash provided by (used in) investing activities | ¥-3.3 billion | Consolidated |
| Interest expenses | ¥0.2 billion | Consolidated |
| Issuance of new shares | ¥3.13 million | Consolidated |
| Gain on reversal of share acquisition rights | ¥0.78 million | Consolidated |
| Provision for shareholder benefit program | ¥32.03 million | Consolidated |
| Income taxes - current | ¥0.8 billion | Consolidated |
| Income taxes | ¥0.7 billion | Consolidated |
| Income taxes - deferred | ¥-30.84 million | Consolidated |
| Impairment loss | ¥0.4 billion | Consolidated |
| Foreign currency translation adjustment net of tax | ¥-21.29 million | Consolidated |
| Extraordinary income | ¥0.3 billion | Consolidated |
| Extraordinary loss | ¥0.5 billion | Consolidated |
| Effect of exchange rate change on cash and cash equivalents | ¥2.74 million | Consolidated |
| Net increase (decrease) in cash and cash equivalents | ¥-0.9 billion | Consolidated |
| Research and development expenses | ¥0.1 billion | Consolidated |
| Income (loss) before income taxes | ¥2.2 billion | Consolidated |
| Income (loss) before income taxes | ¥2.2 billion | Consolidated |
| Ordinary income | ¥2.4 billion | Consolidated |
| Salaries and allowances | ¥2.8 billion | Consolidated |
| Disposal of treasury stock | ¥33.29 million | Consolidated |
| Purchase of treasury stock | ¥-13.23 million | Consolidated |
| Subsidy income | ¥33.93 million | Consolidated |
| Comprehensive income attributable to owners of parent | ¥1.5 billion | Consolidated |
| Net cash provided by (used in) financing activities | ¥0.7 billion | Consolidated |
| Selling, general and administrative expenses | ¥8.9 billion | Consolidated |
| Provision of allowance for doubtful accounts | ¥-1.19 million | Consolidated |
| Provision for bonuses | ¥90.03 million | Consolidated |
| Remeasurements of defined benefit plans net of tax | ¥14.79 million | Consolidated |
| Retirement benefit expenses | ¥54.10 million | Consolidated |
| Comprehensive income attributable to non-controlling interests | ¥33.77 million | Consolidated |
| Net income (loss) attributable to non-controlling interests | ¥20.25 million | Consolidated |
| Other | ¥19.93 million | Parent only |
| Other | ¥2.28 million | Parent only |
| Dividends from surplus | ¥-0.4 billion | Parent only |
| Interest and dividend income | ¥82.81 million | Parent only |
| Rent income | ¥53.10 million | Parent only |
| Operating income | ¥1.1 billion | Parent only |
| Non-operating income | ¥0.2 billion | Parent only |
| Non-operating expenses | ¥0.2 billion | Parent only |
| Loss on retirement of non-current assets | ¥0.43 million | Parent only |
| Rents | ¥46.50 million | Parent only |
| Cost of sales | ¥12.2 billion | Parent only |
| Gross profit (loss) | ¥2.6 billion | Parent only |
| Net sales | ¥14.9 billion | Parent only |
| Net income (loss) | ¥0.7 billion | Parent only |
| Net income (loss) | ¥0.7 billion | Parent only |
| Provision for directors' retirement benefits | ¥12.36 million | Parent only |
| Gain on sales of investment securities | ¥51.06 million | Parent only |
| Loss on valuation of investment securities | ¥42.51 million | Parent only |
| Interest expenses | ¥0.1 billion | Parent only |
| Fee expenses | ¥43.57 million | Parent only |
| Issuance of new shares | ¥3.13 million | Parent only |
| Gain on reversal of share acquisition rights | ¥0.78 million | Parent only |
| Gain on reversal of share acquisition rights | ¥0.78 million | Parent only |
| Provision for shareholder benefit program | ¥85.04 million | Parent only |
| Income taxes - current | ¥0.3 billion | Parent only |
| Income taxes | ¥0.3 billion | Parent only |
| Income taxes - deferred | ¥-25.86 million | Parent only |
| Legal welfare expenses | ¥65.16 million | Parent only |
| Depreciation | ¥21.99 million | Parent only |
| Extraordinary income | ¥0.78 million | Parent only |
| Extraordinary loss | ¥0.1 billion | Parent only |
| Research and development expenses | ¥0.1 billion | Parent only |
| Income (loss) before income taxes | ¥1.0 billion | Parent only |
| Ordinary income | ¥1.2 billion | Parent only |
| Salaries and allowances | ¥0.3 billion | Parent only |
| Disposal of treasury stock | ¥33.29 million | Parent only |
| Purchase of treasury stock | ¥-13.23 million | Parent only |
| Promotion expenses | ¥0.2 billion | Parent only |
| Selling, general and administrative expenses | ¥1.5 billion | Parent only |
| Rent expenses | ¥19.98 million | Parent only |
| Provision for bonuses | ¥18.85 million | Parent only |
| Retirement benefit expenses | ¥4.37 million | Parent only |
| Loss on valuation of shares of subsidiaries and associates | ¥98.70 million | Parent only |
Statement of changes in equity (4 items)
| Item | Value | Consolidated / Non-consolidated |
|---|---|---|
| Total changes during the period | ¥1.2 billion | Consolidated |
| Net changes in items other than shareholders' equity | ¥0.2 billion | Consolidated |
| Total changes during the period | ¥0.3 billion | Parent only |
| Net changes in items other than shareholders' equity | ¥16.80 million | Parent only |
Statement of cash flows (43 items)
| Item | Value | Consolidated / Non-consolidated |
|---|---|---|
| Other | ¥-86.23 million | Consolidated |
| Other | ¥4.26 million | Consolidated |
| Other | ¥-1.12 million | Consolidated |
| Amortization of goodwill | ¥0.3 billion | Consolidated |
| Repayment of lease liabilities-FinCF | ¥-0.2 billion | Consolidated |
| Business structure improvement expenses | ¥16.42 million | Consolidated |
| Increase decrease in notes and accounts payable trade | ¥51.99 million | Consolidated |
| Gain on forgiveness of debts | ¥-0.3 billion | Consolidated |
| Interest expenses paid | ¥-0.2 billion | Consolidated |
| Interest and dividends income received | ¥24.24 million | Consolidated |
| Interest and dividend income | ¥-24.29 million | Consolidated |
| Loss (gain) on sales of fixed assets | ¥2.73 million | Consolidated |
| Loss on retirement of non-current assets | ¥21.54 million | Consolidated |
| Decrease increase in notes and accounts receivable trade | ¥-0.1 billion | Consolidated |
| Proceeds from withdrawal of time deposits | ¥0.2 billion | Consolidated |
| Payments into time deposits | ¥-0.2 billion | Consolidated |
| Subtotal | ¥2.7 billion | Consolidated |
| Increase decrease in provision for directors retirement benefits | ¥33.44 million | Consolidated |
| Purchase of investment securities | ¥-0.3 billion | Consolidated |
| Proceeds from sales of investment securities | ¥0.5 billion | Consolidated |
| Loss (gain) on sales of long-term investment securities | ¥-81.45 million | Consolidated |
| Valuation gains (losses) on investment securities | ¥69.75 million | Consolidated |
| Interest expenses | ¥0.2 billion | Consolidated |
| Proceeds from collection of lease and guarantee deposits | ¥43.81 million | Consolidated |
| Payments for lease and guarantee deposits | ¥-32.24 million | Consolidated |
| Purchase of property plant and equipment and intangible assets | ¥-3.5 billion | Consolidated |
| Proceeds from sales of property plant and equipment and intangible assets | ¥44.73 million | Consolidated |
| Decrease in consumption taxes payable | ¥-0.1 billion | Consolidated |
| Decrease (increase) in inventories | ¥-0.9 billion | Consolidated |
| Income taxes paid | ¥-0.8 billion | Consolidated |
| Depreciation | ¥1.1 billion | Consolidated |
| Impairment loss | ¥0.4 billion | Consolidated |
| Decrease/increase in short-term loans payable | ¥1.1 billion | Consolidated |
| Regarding purchase of treasury stock | ¥-13.23 million | Consolidated |
| Proceeds from subsidy income | ¥33.93 million | Consolidated |
| Subsidy income | ¥-33.93 million | Consolidated |
| Increase (decrease) in allowance for doubtful accounts | ¥-3.62 million | Consolidated |
| Increase (decrease) in provision for bonuses | ¥8.28 million | Consolidated |
| Increase (decrease) in net defined benefit liability | ¥-41.31 million | Consolidated |
| Payments from changes in ownership interests in subsidiaries that do not result in change in scope of consolidation | ¥-1.20 million | Consolidated |
| Dividends | ¥-0.4 billion | Consolidated |
| Proceeds from long term loans payable | ¥1.4 billion | Consolidated |
| Repayment of long term loans payable | ¥-1.2 billion | Consolidated |
Basic indicators
| Item | Value | Consolidated / Non-consolidated | Source |
|---|---|---|---|
| Net cash provided by (used in) operating activities | ¥1.8 billion | Consolidated | Disclosed |
| Dividend per share | 34 | Parent only | Disclosed |
| Number of employees | 1,008 | Consolidated | Disclosed |
| Net assets | ¥15.2 billion | Consolidated | Disclosed |
| Net sales | ¥32.7 billion | Consolidated | Disclosed |
| Operating income | ¥2.4 billion | Consolidated | Disclosed |
| Ordinary income | ¥2.4 billion | Consolidated | Disclosed |
| Net income | ¥1.4 billion | Consolidated | Disclosed |
| Total assets | ¥48.7 billion | Consolidated | Disclosed |
| Operating margin | 7.4% | Consolidated | Calculated |
| Net margin | 4.4% | Consolidated | Calculated |
| Sales per employee | 32395855 yen | Consolidated | Calculated |
| Total asset turnover | 0.67 times | Consolidated | Calculated |
| Net assets to total assets | 31.2% | Consolidated | Calculated |